Expression of long non-coding RNA FRAPT in triple-negative breast cancer and its biological significance
10.13200/j.cnki.cjb.003885
- VernacularTitle:长链非编码核糖核酸FRAPT在三阴性乳腺癌中的表达及其生物学意义
- Author:
HE Sai
- Publication Type:Journal Article
- Keywords:
Triple-negative breast cancer(TNBC);
LncRNA FRAPT;
Proliferation;
Cell cycle;
Drug resistance
- From:
Chinese Journal of Biologicals
2023;36(5):580-584
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the expression of long non-coding RNA FRAPT(lncRNA FRAPT) in triple-negative breast cancer(TNBC) cells and analyze its effects on proliferation,cell cycle and drug resistance of TNBC cells.Methods Using scRNASeqDB and TCGA on-line bioinformatics database,the expression of lncRNA FRAPT in TNBC and its correlation with prognosis were detected;TNBC cell line MDA-MB-231 was transfected with si-lncRNA FRAPT and si-Ctrl(negative control) by using Lipofectamine~(TM) 2000 respectively,of which the proliferation and cell cycle changes after transfection were detected by SRB test and flow cytometry,and the drug resistance to chemotherapy drug paclitaxel(PTX)was detected.Results The expression of lncRNA FRAPT was up-regulated in TNBC tissues and cells,and its high expression was positively correlated with the poor prognosis of TNBC patients(Hazard Ratio=1.66,P=0.047).Silencing lncRNA FRAPT significantly inhibited the proliferation of TNBC cells,with the cell cycle arrested in G1 phase,while increased the sensitivity of TNBC cells to PTX.Conclusion LncRNA FRAPT was highly expressed in TNBC and related to tumor prognosis-Silencing lncRNA FRAPT inhibited proliferation and cell cycle of TNBC,and increased the sensitivity to chemotherapy drug PTX.
